A detailed history of Curated Wealth Partners LLC transactions in Pfizer Inc stock. As of the latest transaction made, Curated Wealth Partners LLC holds 35,453 shares of PFE stock, worth $1.05 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
35,453
Previous 29,848 18.78%
Holding current value
$1.05 Million
Previous $828,000 19.69%
% of portfolio
0.14%
Previous 0.12%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$25.26 - $29.6 $895,542 - $1.05 Million
35,453 New
35,453 $991,000
Q4 2023

Jan 08, 2024

BUY
$26.13 - $33.94 $494,614 - $642,450
18,929 Added 199.32%
28,426 $818,000
Q3 2023

Oct 23, 2023

SELL
$32.09 - $37.51 $40,401 - $47,225
-1,259 Reduced 11.71%
9,497 $315,000
Q2 2023

Jul 10, 2023

SELL
$36.12 - $41.79 $390,204 - $451,457
-10,803 Reduced 50.11%
10,756 $394,000
Q1 2023

Apr 27, 2023

SELL
$39.39 - $51.28 $13,589 - $17,691
-345 Reduced 1.58%
21,559 $879,000
Q4 2022

Jan 30, 2023

SELL
$41.75 - $54.5 $89,261 - $116,521
-2,138 Reduced 8.89%
21,904 $1.12 Million
Q3 2022

Oct 13, 2022

BUY
$43.76 - $53.42 $4,507 - $5,502
103 Added 0.43%
24,042 $1.05 Million
Q2 2022

Jul 27, 2022

BUY
$46.53 - $55.17 $187,795 - $222,666
4,036 Added 20.28%
23,939 $1.25 Million
Q4 2021

Feb 03, 2022

BUY
$41.32 - $61.25 $619 - $918
15 Added 0.08%
19,903 $1.18 Million
Q3 2021

Nov 08, 2021

SELL
$39.25 - $50.42 $13,423 - $17,243
-342 Reduced 1.69%
19,888 $855,000
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $90,960 - $103,042
2,533 Added 14.31%
20,230 $792,000
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $105,426 - $118,899
3,148 Added 21.64%
17,697 $641,000
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $486,955 - $619,205
14,549 New
14,549 $535,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Curated Wealth Partners LLC Portfolio

Follow Curated Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Curated Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Curated Wealth Partners LLC with notifications on news.